Hexima (ASX:HXL) EV-to-EBITDA : 0.10 (As of May. 05, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Hexima EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Hexima's enterprise value is A$-0.08 Mil. Hexima's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.75 Mil. Therefore, Hexima's EV-to-EBITDA for today is 0.10.

The historical rank and industry rank for Hexima's EV-to-EBITDA or its related term are showing as below:

ASX:HXL' s EV-to-EBITDA Range Over the Past 10 Years
Min: -9.91 Med: 0 Max: 5.48
Current: 0.1

During the past 7 years, the highest EV-to-EBITDA of Hexima was 5.48. The lowest was -9.91. And the median was 0.00.

ASX:HXL's EV-to-EBITDA is ranked better than
92.21% of 462 companies
in the Biotechnology industry
Industry Median: 9.55 vs ASX:HXL: 0.10

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-05), Hexima's stock price is A$0.011. Hexima's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.004. Therefore, Hexima's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Hexima EV-to-EBITDA Historical Data

The historical data trend for Hexima's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hexima EV-to-EBITDA Chart

Hexima Annual Data

Trend

Jun08

Jun09

Jun10

Jun20

Jun21

Jun22

Jun23

EV-to-EBITDA

Get a 7-Day Free Trial

-2.87

-0.11

-0.70

Hexima Semi-Annual Data
	Dec06	Dec07	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial										-	-0.11	-	-0.70	-

Competitive Comparison of Hexima's EV-to-EBITDA

For the Biotechnology subindustry, Hexima's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hexima's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hexima's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Hexima's EV-to-EBITDA falls into.

Hexima EV-to-EBITDA Calculation

Hexima's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	-0.076	/	-0.753
	=	0.10

Hexima's current Enterprise Value is A$-0.08 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hexima's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.75 Mil.

Hexima (ASX:HXL) EV-to-EBITDA Explanation

Hexima's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.011	/	-0.004
	=	At Loss

Hexima's share price for today is A$0.011.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hexima's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.004.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Hexima EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Hexima's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Hexima (ASX:HXL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hexima Ltd (ASX:HXL) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

84-90 Hotham Street, Corporate One, Preston, VIC, AUS, 3072

Website

https://www.hexima.com.au

Hexima Ltd is a biotechnology company. The company is engaged in the research and development of plant-derived proteins and peptides for applications as human therapeutics.